Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter

Nucleic Acids Research

Volumn 42, Issue 3, 2014, Pages 1563-1574

  Chen, Hui ^a,b   Kazemier, Hinke G ^a   De Groote, Marloes L ^a   Ruiters, Marcel H J ^a,c   Xu, Guo Liang ^b   Rots, Marianne G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^c Synvolux Therapeutics Inc   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; CELL LINE, TUMOR; DIOXYGENASES; DNA; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; HEK293 CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MICE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; TRANSCRIPTIONAL ACTIVATION; ZINC FINGERS;

EID: 84894248678     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt1019     Document Type: Article

References (73)

1. Bird, A. (2002) DNA methylation patterns and epigenetic memory. Genes Dev., 16, 6-21.
2. Goll, M.G. and Bestor, T.H. (2005) Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem., 74, 481-514.
3. De Carvalho, D.D., You, J.S. and Jones, P.A. (2010) DNA methylation and cellular reprogramming. Trends Cell Biol., 20, 609-617.
4. Deaton, A.M. and Bird, A. (2011) CpG islands and the regulation of transcription. Genes Dev., 25, 1010-1022.
5. Wu, S.C. and Zhang, Y. (2010) Active DNA demethylation: many roads lead to Rome. Nat. Rev. Mol. Cell Biol., 11, 607-620.
6. Oswald, J., Engemann, S., Lane, N., Mayer, W., Olek, A., Fundele, R., Dean, W., Reik, W. and Walter, J. (2000) Active demethylation of the paternal genome in the mouse zygote. Curr. Biol., 10, 475-478.
7. Mayer, W., Niveleau, A., Walter, J., Fundele, R. and Haaf, T. (2000) Demethylation of the zygotic paternal genome. Nature, 403, 501-502.
8. Morgan, H.D., Santos, F., Green, K., Dean, W. and Reik, W. (2005) Epigenetic reprogramming in mammals. Hum. Mol. Genet., 14, R47-R58.
9. Dawlaty, M.M., Ganz, K., Powell, B.E., Hu, Y.C., Markoulaki, S., Cheng, A.W., Gao, Q., Kim, J., Choi, S.W., Page, D.C. et al. (2011) Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. Cell Stem Cell, 9, 166-175.
10. Gu, T.P., Guo, F., Yang, H., Wu, H.P., Xu, G.F., Liu, W., Xie, Z.G., Shi, L., He, X., Jin, S.G. et al. (2011) The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature, 477, 606-610.
11. Wu, H. and Zhang, Y. (2011) Mechanisms and functions of tet protein-mediated 5-methylcytosine oxidation. Genes Dev., 25, 2436-2452.
12. Hajkova, P., Erhardt, S., Lane, N., Haaf, T., El-Maarri, O., Reik, W., Walter, J. and Surani, M.A. (2002) Epigenetic reprogramming in mouse primordial germ cells. Mech. Dev., 117, 15-23.
13. Sasaki, H. and Matsui, Y. (2008) Epigenetic events in mammalian germ-cell development: reprogramming and beyond. Nat. Rev. Genet., 9, 129-140.
14. Meissner, A., Mikkelsen, T.S., Gu, H., Wernig, M., Hanna, J., Sivachenko, A., Zhang, X., Bernstein, B.E., Nusbaum, C., Jaffe, D.B. et al. (2008) Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature, 454, 766-770.
15. Lister, R., Pelizzola, M., Dowen, R.H., Hawkins, R.D., Hon, G., Tonti-Filippini, J., Nery, J.R., Lee, L., Ye, Z., Ngo, Q.M. et al. (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature, 462, 315-322.
16. Rots, M.G. and Peterson, S.K. (2013) A symphony on C: orchestrating DNA repair for gene expression via cytosine modification. Epigenomics, 5, 315-322.
17. Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L.M., Liu, D.R., Aravind, L. et al. (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science, 324, 930-935.
18. Wyatt, G.R. and Cohen, S.S. (1952) A new pyrimidine base from bacteriophage nucleic acids. Nature, 170, 1072-1073.
19. Penn, N.W., Suwalski, R., O'Riley, C., Bojanowski, K. and Yura, R. (1972) The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. Biochem. J., 126, 781-790.
20. Kothari, R.M. and Shankar, V. (1976) 5-methylcytosine content in the vertebrate deoxyribonucleic acids: species specificity. J. Mol. Evol., 7, 325-329.
21. Globisch, D., Munzel, M., Muller, M., Michalakis, S., Wagner, M., Koch, S., Bruckl, T., Biel, M. and Carell, T. (2010) Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS One, 5, e15367.
22. Kriaucionis, S. and Heintz, N. (2009) The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science, 324, 929-930.
23. Nestor, C.E., Ottaviano, R., Reddington, J., Sproul, D., Reinhardt, D., Dunican, D., Katz, E., Dixon, J.M., Harrison, D.J. and Meehan, R.R. (2011) Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res., 22, 467-477.
24. Song, C.X., Szulwach, K.E., Fu, Y., Dai, Q., Yi, C., Li, X., Li, Y., Chen, C.H., Zhang, W., Jian, X. et al. (2011) Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotechnol., 29, 68-72.
25. Szwagierczak, A., Bultmann, S., Schmidt, C.S., Spada, F. and Leonhardt, H. (2010) Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res., 38, e181.
26. Ito, S., D'Alessio, A.C., Taranova, O.V., Hong, K., Sowers, L.C. and Zhang, Y. (2010) Role of tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature, 466, 1129-1133.
27. Ko, M., Huang, Y., Jankowska, A.M., Pape, U.J., Tahiliani, M., Bandukwala, H.S., An, J., Lamperti, E.D., Koh, K.P., Ganetzky, R. et al. (2010) Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature, 468, 839-843.
28. Cortellino, S., Xu, J., Sannai, M., Moore, R., Caretti, E., Cigliano, A., Le Coz, M., Devarajan, K., Wessels, A., Soprano, D. et al. (2011) Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell, 146, 67-79.
29. Guo, J.U., Su, Y., Zhong, C., Ming, G.L. and Song, H. (2011) Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell, 145, 423-434.
30. Ito, S., Shen, L., Dai, Q., Wu, S.C., Collins, L.B., Swenberg, J.A., He, C. and Zhang, Y. (2011) Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science, 333, 1300-1303.
31. He, Y.F., Li, B.Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L. et al. (2011) Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science, 333, 1303-1307.
32. Nabel, C.S. and Kohli, R.M. (2011) Molecular biology. demystifying DNA. Demethylation. Science, 333, 1229-1230.
33. Schiesser, S., Hackner, B., Pfaffeneder, T., Muller, M., Hagemeier, C., Truss, M. and Carell, T. (2012) Mechanism and stem-cell activity of 5-carboxycytosine decarboxylation determined by isotope tracing. Angew. Chem. Int. Ed Engl., 51, 6516-6520.
34. Maiti, A. and Drohat, A.C. (2011) Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites. J. Biol. Chem., 286, 35334-35338.
35. De Smet, C., Lurquin, C., Lethe, B., Martelange, V. and Boon, T. (1999) DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol. Cell Biol., 19, 7327-7335.
36. Robertson, K.D. (2005) DNA methylation and human disease. Nat. Rev. Genet., 6, 597-610.
37. Watanabe, Y. and Maekawa, M. (2010) Methylation of DNA in cancer. Adv. Clin. Chem., 52, 145-167.
38. de Groote, M.L., Verschure, P.J. and Rots, M.G. (2012) Epigenetic editing: Targeted rewriting of epigenetic marks to modulate expression of selected target genes. Nucleic Acids Res., 40, 10596-10613.
39. Klose, R.J. and Zhang, Y. (2007) Histone H3 Arg2 methylation provides alternative directions for COMPASS. Nat. Struct. Mol. Biol., 14, 1058-1060.
40. de Groote, M.L., Kazemier, H.G., Huisman, C., Van der Gun, B.T.F., Faas, M.M. and Rots, M.G. (2013) Re-expression of epigenetically silenced ICAM-1 elucidates its cell-biological role in ovarian cancer cells. Int. J. Cancer, July 5 (doi:10.1002/ijc.28375; Epub ahead of print).
41. van der Gun, B.T.F., Huisman, C., Stolzenburg, S., Kazemier, H.G., Ruiters, M.H., Blancafort, P. and Rots, M.G. (2013) Bidirectional modulation of endogenous EpCAM expression to unravel its function in ovarian cancer. Br. J. Cancer, 108, 881-886.
42. Magnenat, L., Blancafort, P. and Barbas, C.F. 3rd (2004) In vivo selection of combinatorial libraries and designed affinity maturation of polydactyl zinc finger transcription factors for ICAM-1 provides new insights into gene regulation. J. Mol. Biol., 341, 635-649.
43. Huisman, C., Wisman, G.B., Kazemier, H.G., van Vugt, M.A., van der Zee, A.G., Schuuring, E. and Rots, M.G. (2013) Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by artificial transcription factors. Mol. Oncol., 7, 669-679.
44. Booth, M.J., Branco, M.R., Ficz, G., Oxley, D., Krueger, F., Reik, W. and Balasubramanian, S. (2012) Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science, 336, 934-937.
45. Haffner, M.C., Chaux, A., Meeker, A.K., Esopi, D.M., Gerber, J., Pellakuru, L.G., Toubaji, A., Argani, P., Iacobuzio-Donahue, C., Nelson, W.G. et al. (2011) Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget, 2, 627-637.
46. Yang, H., Liu, Y., Bai, F., Zhang, J.Y., Ma, S.H., Liu, J., Xu, Z.D., Zhu, H.G., Ling, Z.Q., Ye, D. et al. (2013) Tumor development is associated with decrease of TET gene expression and 5- methylcytosine hydroxylation. Oncogene, 32, 663-669.
47. van der Gun, B.T., de Groote, M.L., Kazemier, H.G., Arendzen, A.J., Terpstra, P., Ruiters, M.H., McLaughlin, P.M. and Rots, M.G. (2011) Transcription factors and molecular epigenetic marks underlying EpCAM overexpression in ovarian cancer. Br. J. Cancer, 105, 312-319.
48. Lavie, L., Maldener, E., Brouha, B., Meese, E. and Mayer, J. (2004) The human L1 promoter: variable transcription initiation sites and a major impact of upstream flanking sequence on promoter activity. Genome Res., 14, 2253-2260.
49. Beltran, A.S. and Blancafort, P. (2011) Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs). Epigenetics, 6, 224-235.
50. Williams, K., Christensen, J., Pedersen, M.T., Johansen, J.V., Cloos, P.A., Rappsilber, J. and Helin, K. (2011) TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature, 473, 343-348.
51. Deplus, R., Delatte, B., Schwinn, M.K., Defrance, M., Mendez, J., Murphy, N., Dawson, M.A., Volkmar, M., Putmans, P., Calonne, E. et al. (2013) TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J., 32, 645-655.
52. Chen, Q., Chen, Y., Bian, C., Fujiki, R. and Yu, X. (2013) TET2 promotes histone O-GlcNAcylation during gene transcription. Nature, 493, 561-564.
53. Fujiki, R., Hashiba, W., Sekine, H., Yokoyama, A., Chikanishi, T., Ito, S., Imai, Y., Kim, J., He, H.H., Igarashi, K. et al. (2011) GlcNAcylation of histone H2B facilitates its monoubiquitination. Nature, 480, 557-560.
54. Branco, M.R., Ficz, G. and Reik, W. (2011) Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat. Rev. Genet., 13, 7-13.
55. Iqbal, K., Jin, S.G., Pfeifer, G.P. and Szabo, P.E. (2011) Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc. Natl Acad. Sci. USA, 108, 3642-3647.
56. Pogribny, I.P., Pogribna, M., Christman, J.K. and James, S.J. (2000) Single-site methylation within the p53 promoter region reduces gene expression in a reporter gene construct: Possible in vivo relevance during tumorigenesis. Cancer Res., 60, 588-594.
57. Portela, A. and Esteller, M. (2010) Epigenetic modifications and human disease. Nat. Biotechnol., 28, 1057-1068.
58. Martin, D.I., Cropley, J.E. and Suter, C.M. (2011) Epigenetics in disease: leader or follower? Epigenetics, 6, 843-848.
59. Kleinman, M.E., Yamada, K., Takeda, A., Chandrasekaran, V., Nozaki, M., Baffi, J.Z., Albuquerque, R.J., Yamasaki, S., Itaya, M., Pan, Y. et al. (2008) Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature, 452, 591-597.
60. Olejniczak, M., Polak, K., Galka-Marciniak, P. and Krzyzosiak, W.J. (2011) Recent advances in understanding of the immunological off-target effects of siRNA. Curr. Gene Ther., 11, 532-543.
61. Brenet, F., Moh, M., Funk, P., Feierstein, E., Viale, A.J., Socci, N.D. and Scandura, J.M. (2011) DNA methylation of the first exon is tightly linked to transcriptional silencing. PLoS One, 6, e14524.
62. Jones, P.A. (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet., 13, 484-492.
63. Raynal, N.J., Si, J., Taby, R.F., Gharibyan, V., Ahmed, S., Jelinek, J., Estecio, M.R. and Issa, J.P. (2012) DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memory. Cancer Res., 72, 1170-1181.
64. Feng, Y.Q., Desprat, R., Fu, H., Olivier, E., Lin, C.M., Lobell, A., Gowda, S.N., Aladjem, M.I. and Bouhassira, E.E. (2006) DNA methylation supports intrinsic epigenetic memory in mammalian cells. PLoS Genet., 2, e65.
65. Gregory, D.J., Mikhaylova, L. and Fedulov, A.V. (2012) Selective DNA demethylation by fusion of TDG with a sequence-specific DNA-binding domain. Epigenetics, 7, 344-349.
66. Zhu, B., Zheng, Y., Hess, D., Angliker, H., Schwarz, S., Siegmann, M., Thiry, S. and Jost, J.P. (2000) 5-methylcytosine-DNA glycosylase activity is present in a cloned G/T mismatch DNA glycosylase associated with the chicken embryo DNA demethylation complex. Proc. Natl Acad. Sci. USA, 97, 5135-5139.
67. Stolzenburg, S., Rots, M.G., Beltran, A.S., Rivenbark, A.G., Yuan, X., Qian, H., Strahl, B.D. and Blancafort, P. (2012) Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer. Nucleic Acids Res., 40, 6725-6740.
68. Falahi, F., Huisman, C., Kazemier, H.G., Kok, K., Hospers, G.A.P. and Rots, M.G. (2013) Towards sustained silencing of Her2/neu in cancer by epigenetic editing. Mol. Cancer Res., 11, 1029-1039.
69. Rivenbark, A.G., Stolzenburg, S., Beltran, A.S., Yuan, X., Rots, M.G., Strahl, B.D. and Blancafort, P. (2012) Epigenetic reprogramming of cancer cells via targeted DNA methylation. Epigenetics, 7, 350-360.
70. Siddique, A.N., Nunna, S., Rajavelu, A., Zhang, Y., Jurkowska, R.Z., Reinhardt, R., Rots, M.G., Ragozin, S., Jurkowski, T.P. and Jeltsch, A. (2013) Targeted methylation and gene silencing of VEGF-A in human cells by using a designed Dnmt3a-Dnmt3L single-chain fusion protein with increased DNA methylation activity. J. Mol. Biol., 425, 479-491.
71. van der Gun, B.T.F., Maluszynska-Hoffman, M., Kiss, A., Arendzen, A.J., Ruiters, M.H., McLaughlin, P.M., Weinhold, E. and Rots, M.G. (2010) Targeted DNA methylation by a DNA methyltransferase coupled to a triple helix forming oligonucleotide to down-regulate the epithelial cell adhesion molecule. Bioconjug. Chem., 21, 1239-1245.
72. Pandian, G.N., Ohtsuki, A., Bando, T., Sato, S., Hashiya, K. and Sugiyama, H. (2012) Development of programmable small DNA-binding molecules with epigenetic activity for induction of core pluripotency genes. Bioorg. Med. Chem., 20, 2656-2660.
73. Slaska, K.K., Timar, E. and Kiss, A. (2012) Complementation between inactive fragments of SssI DNA methyltransferase. BMC Mol. Biol., 13, 13-17.